StockData
Petros Pharmaceuticals, Inc. logo

Petros Pharmaceuticals, Inc. (PTPI) stock

PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$0.00+0.00 (+5.56%)

Close on Oct 19, 2026Market cap $135.07KP/E –Yield –

Petros Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Petros Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $5.11M. For fiscal 2024 it was $5.11M, down 12.2% from the year before. The highest annual figure on record is $9.56M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2024Dec 31, 2024$5.11M-12.2%
FY2023Dec 31, 2023$5.82M-2.8%
FY2022Dec 31, 2022$5.99M-23.3%
FY2021Dec 31, 2021$7.81M-18.3%
FY2020Dec 31, 2020$9.56M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$725.40K-56.7%
Q3 FY2024Sep 30, 2024$1.58M-20.9%
Q2 FY2024Jun 30, 2024$1.42M-43.5%
Q1 FY2024Mar 31, 2024$1.39M+74.0%
Q3 FY2023Sep 30, 2023$1.67M-60.0%
Q2 FY2023Jun 30, 2023$1.99M-19.1%
Q1 FY2023Mar 31, 2023$2.52M+2.5%
Q4 FY2022Dec 31, 2022$798.10K-80.4%
Q2 FY2022Jun 30, 2022$4.19M+42.9%
Q1 FY2022Mar 31, 2022$2.47M-28.8%
Q2 FY2021Jun 30, 2021$2.46M+78.9%
Q1 FY2021Mar 31, 2021$4.08M+127.4%
Q4 FY2020Dec 31, 2020$2.93M–
Q3 FY2020Sep 30, 2020$3.46M–
Q2 FY2020Jun 30, 2020$1.37M–
Q1 FY2020Mar 31, 2020$1.79M–

More Petros Pharmaceuticals figures

See a number that looks wrong?